103 / 119
102
Diretrizes AMB
14. Reich K, Nestle FO, Papp K, Ortonne JP, Evans R, Guzzo C, Li S, Dooley
LT, Griffiths CE; EXPRESS study investigators. Infliximab induction and
maintenance therapy for moderate-to-severe psoriasis: a phase III,
multicentre, double-blind trial. Lancet. 2005 Oct 15-21;366(9494):1367-74.
PubMed PMID: 16226614.
15. Gottlieb AB, Evans R, Li S, Dooley LT, Guzzo CA, Baker D, Bala M,
Marano CW, Menter A. Infliximab induction therapy for patients with
severe plaque-type psoriasis: a randomized, double-blind, placebo-